Aria Biosystems

About:

Aria Biosystems, located in Menlo Park, Calif., is developing and commercializing tools to make the detection and analysis of biomolecules.

Website: http://www.ariabiosystems.com/

Top Investors: Versant Ventures, Alloy Ventures, Agilent Ventures, Latterell Venture Partners

Description:

Aria Biosystems is a venture-capital funded life science company developing analytical systems to provide rapid, real-time results for protein quantification or characterization of protein-protein interaction. These systems enable real-time analysis of biomolecular interactions in micro-volume sample sizes, providing information on affinity, kinetics and concentration. Aria utilizes proprietary bio-layer interferometry (BLI) that enables self-calibration and measurement of molecular interactions using simple-to-use and inexpensive instrumentation. The entire analysis can be completed within minutes and does not require labeling of either probe or target. Aria's analytical capabilities provide greater value in applications where existing methods such as HPLC, ELISA and surface plasmon resonance (SPR) have limitations in throughput, performance and cost.

Total Funding Amount:

$5.5M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2004-01-01

Contact Email:

info(AT)ariabiosystems.com

Founders:

Number of Employees:

Last Funding Date:

2004-06-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai